U.S. federal hashish regulation is at a pivotal second heading into 2026. In a January fifteenth webinar, attorneys Jason Adelstone and Vince Sliwoski examined two main federal developments which can be poised to reshape the business: the Government Order directing the rescheduling of marijuana underneath the Managed Substances Act, and new Congressional laws redefining “hemp,” efficient later this yr.
Marijuana rescheduling from Schedule I to Schedule III may have far-reaching implications for state-licensed hashish companies, together with potential aid from IRC Part 280E, expanded analysis alternatives, and shifts in how regulators and repair suppliers method the business. On the similar time, rescheduling raises essential questions on implementation, company rulemaking, and state-level responses.
On the hemp aspect, Congress’s transfer to redefine “hemp” threatens to remove many intoxicating hemp merchandise at present available on the market. Whereas the regulation is critical, uncertainty stays round enforcement, future laws, and attainable authorized challenges—making 2026 a vital yr for hemp firms to reassess threat and compliance methods.
The webinar targeted on what these modifications imply in observe, the place uncertainty stays, and the way companies and stakeholders can put together as federal coverage continues to evolve. Jason and Vince answered many viewers questions throughout the hour. Take pleasure in!
Watch the webinar replay right here
